Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2020 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

PALATINE, Ill., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced an amendment to its License, Development and Commercialization Agreement (“Agreement”)...
August 14, 2020 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results

PALATINE, Ill., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of...
June 29, 2020 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces First Quarter 2020 Financial Results

PALATINE, Ill., June 29, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of...
March 30, 2020 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results

PALATINE, Ill., March 30, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...
March 23, 2020 16:10 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Provides an Update on the Development of LTX-03

PALATINE, Ill., March 23, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), today announced that Abuse Deterrent Pharma, LLC, its licensee of LTX-03 (Hydrocodone Bitartrate and...
February 28, 2020 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results

PALATINE, Ill., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of...
February 10, 2020 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results

PALATINE, Ill., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...
January 02, 2020 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Provides an Update on the Development of LTX-03

PALATINE, Ill., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today provided an update on its development of LTX-03 (Hydrocodone Bitartrate and Acetaminophen)...
October 01, 2019 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces First Quarter 2019 Financial Results

PALATINE, Ill., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...
September 16, 2019 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results

PALATINE, Ill., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...